RIPE-KG · Version 1.1.0 · Resource
ripekg:work/RIPEWE39A6FCE44ACDB86
https://w3id.org/ripe/ripe-kg/work/RIPEWE39A6FCE44ACDB86
| Subject | Predicate | Object |
|---|---|---|
ripekg:work/10.1371%2Fjournal.pone.0279347Does receiving a SARS-CoV-2 antibody test result change COVID-19 protective behaviors? Testing risk compensation in undergraduate students with a randomized controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWE39A6FCE44ACDB86Effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe COVID-19 |
ripekg:work/RIPEWE39A6FCE44ACDB86Effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe COVID-19 |
dcterms:title |
Effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe COVID-19 |
ripekg:work/RIPEWE39A6FCE44ACDB86Effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe COVID-19 |
rdf:type |
node1 |
ripekg:work/RIPEWE39A6FCE44ACDB86Effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe COVID-19 |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/RIPEWE39A6FCE44ACDB86Effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe COVID-19 |
rdf:type |
rdfs:Resource |
ripekg:work/RIPEWE39A6FCE44ACDB86Effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe COVID-19 |
rdf:type |
owl:Thing |
ripekg:work/RIPEWE39A6FCE44ACDB86Effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe COVID-19 |
rdf:type |
prov:Entity |
ripekg:work/RIPEWE39A6FCE44ACDB86Effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe COVID-19 |
rdf:type |
ripe:WorkWork |